| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-05 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.09 | 0.004 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |